PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
09-Dec-2021 Aqilion focuses on treatments for inflammatory diseases, updates company pipeline AQILION AB
09-Dec-2021 Evusheld (formerly AZD7442) long-acting antibody combination authorised for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19 AstraZeneca
09-Dec-2021 New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster Trince
09-Dec-2021 Apogenix Receives EUR 20.7 Million in Public Funding for Pivotal Study and Preparation for Market Production of Asunercept for the Treatment of COVID-19 Apogenix AG
09-Dec-2021 Vetter Wins Frost & Sullivan’s 2021 Global Customer Value Leadership Award, and Looks Back on a Stable Year Under Ongoing Pandemic Circumstances Vetter
09-Dec-2021 F-star Therapeutics to Present FS222 Trial-in-Progress Update at ESMO Immuno-Oncology Congress 2021 F-star Therapeutics
09-Dec-2021 PureTech Advances Wholly-Owned Candidate LYT-300 (Oral Allopregnanolone) into Clinical Study For Potential Treatment of Neurological and Neuropsychological Conditions PureTech Health plc
09-Dec-2021 ATP Launches Adendra Therapeutics, a New Kind of Immunotherapy Company Deploying Novel Insights into Dendritic Cell Biology, with $53M Series A ATP (Apple Tree Partners),
09-Dec-2021 Biocomposites Signs Distribution Agreement with NuVasive Specialized Orthopedics to supply STIMULAN® in Germany Biocomposites
09-Dec-2021 Sosei Heptares Receives Grant Funding from Wellcome to Advance the Development of Potent, Differentiated Oral Anti-Viral Small Molecules to Treat COVID-19 Sosei Heptares
09-Dec-2021 Nordic Nanovector to present at 3rd Targeted Radiopharmaceutical Summit 2021 Nordic Nanovector ASA
09-Dec-2021 New study confirms that purity and type of coating biomaterials used in 2D cell culturing are crucial for efficient stem cell proliferation Sciad Newswire
09-Dec-2021 Formycon and Scientists from TUM publish new Data on broadly effective SARS-CoV-2 antiviral Drug FYB207 Formycon AG
09-Dec-2021 Zur Rose Group successfully completed capital increase from authorised capital and sets placement price at CHF 290 per new share Zur Rose Group AG
08-Dec-2021 Biotest AG: Biotest adjusts guidance Biotest AG
08-Dec-2021 Biotest AG: Reduction of guidance Biotest AG
08-Dec-2021 Zur Rose Group decides on capital increase from authorised capital and starts accelerated bookbuilding to make full use of increasing market opportunities Zur Rose Group AG
08-Dec-2021 BRAIN Biotech AG: Additional Genome Editing Nuclease: BRAIN-Metagenome-Cas 01 (BMC01) BRAIN Biotech AG
08-Dec-2021 BRAIN Biotech AG: Additional Differentiated Genome-Editing Nuclease: BRAIN-Metagenome-Cas 01 (BMC01) BRAIN Biotech AG
08-Dec-2021 SOTIO Announces Clinical Collaboration with MSD to Evaluate IL-15 Superagonist, SOT101, in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors B3C newswire